Ingevity (NYSE: NGVT) reported Q2 EPS of $1.73, $0.11 better than the analyst estimate of $1.62. Revenue for the quarter came in at $419.9 million versus the consensus estimate of $409.67 million.

GUIDANCE:

Ingevity sees FY2022 revenue of $1.53-1.65 billion, versus the consensus of $1.59 billion.

• adjusted EBITDA between $430 million to $470 million.

For earnings history and earnings-related data on Ingevity (NGVT) click here.